Safe, Effective, and More Tolerable 16 Tablets Colon Prep
NCT ID: NCT00817934
Last Updated: 2009-01-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
400 participants
OBSERVATIONAL
2009-01-31
2010-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus a Sodium Picosulfate and Magnesium Salt Solution Using Day Before-Only Dosing Regimen in Adults.
NCT02273141
Study of Efficacy of Bowel Preparation Before Colonoscopy
NCT00771485
BLI850 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy
NCT00756977
Single Dose Versus Split Dose Polyethylene Glycol-based Colonic Lavage for Colonoscopy
NCT01610856
Study to Assess the Tolerability, Safety and Efficacy of an Adapted Gut Cleansing Solution in Routine Colon Cleansing Prior to Colonoscopies
NCT01251237
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The AB Prep is a 16 tablets prep that has excellent patient's tolerance efficacy, with no change in blood electrolytes or EKG. ( PhaseI (20 patients) and Phase II (200 patients)
The protocol that was used is as follows:
(IND application # 75,704)
Protocol design for testing the safety and efficacy of the AB Prep:
The AB Prep is a combination of 2 Reglan tablets (10mg each), 6 Dulcolax tablets, and 8 K-Phos Neutral tablets. The combination is given in two steps, four hours apart; the day before the colonoscopy.
As before, the objective of this clinical trial is to examine the AB Prep first and foremost for safety, and second for efficacy of colon cleansing.
The proposed trial is for One-Arm Study of subjects undergoing elective and therapeutic colonoscopy.
Phase III: 400 patients, The selection will be random, the age probably ranging from 12 to 75 years old.
The patients will have a Pre, and post procedural EKG, comprehensive (Sodium, Potassium, Creatinine, BUN, Calcium, Magnesium, Phosphate, Glucose), and vital signs.
The patients with severe constipation (One bowel movement per week or more) will not be included in the study. (In our experience, those people required two days prep to achieve colon cleansing).
The SRSS statistical program will be used for data collection and analysis:
The end point of the study is colon cleansing, adequate enough to perform colonoscopy. The colon cleansing will be graded as follow:
1. Poor colon prep, unable to proceed with colonoscopy.
2. Able to do colonoscopy with, the colon cleansing labeled as:
A- Excellent, Totally cleansed B- Good, adequately cleansed, with need for irrigation.
In addition to efficacy, we would like to check for patient's satisfaction and compliance, (Most common complaints that the patients tend to voice with the present approved colon preps).
Patient's satisfaction data will be collected before the procedure and will be graded as follow:
1. Totally satisfied with the Prep, without any complaints
2. Satisfied, with the following complaints (Nausea, vomiting, abdominal pain/cramping)
3. Unsatisfied with the Prep (Reasons!!!)
Patient's compliance will be graded as follow:
1. Compliant
2. Non compliant(Reasons).
The prep instruction will be as follows REPARATION FOR COLONOSCOPY
FIVE DAYS before your procedure:
1. If you take COUMADIN or PLAVIX, we recommend that you stop these medications. You must contact your primary care physician or cardiologist for specific instructions. You may restart these medications again after the procedure unless otherwise instructed.
2. If you have DIABETES and take medication to control your blood sugar, contact your primary care physician or diabetes doctor for instructions about how to take your diabetes medication while preparing for this procedure.
3. Stop taking iron or multivitamins that contain iron.
4. Avoid the use of aspirin and aspirin-like medications such as ibuprofen, Advil and Aleve. These medicines may increase your risk of bleeding after polyp removal.
5. Start a low-roughage diet and do not eat corn or raw vegetables. You may re-start your usual diet after the procedure.
TWO DAYS before the procedure:
1\. Take 2 tablets of Dulcolax at 8:00 PM.
ONE DAY before the procedure:
1. Begin a clear liquid diet at breakfast and continue this diet until 4 hours before your procedure. A clear liquid diet includes: water, tea, black coffee, clear broth, apple juice, white grape juice, Gatorade, soda, Jell-O. Do not eat or drink anything red, including red Jell-O. Do not drink milk. Do not use sugar-free drinks. All patients, including those with DIABETES, should be sure they get enough sugar during this time.
2. At 8:00 AM, take One Reglan(10mg) tablet, 2 Dulcolax tablets, and 4 tablets of K-PHOS NEUTRAL. Drink three glasses of water/juice SLOWLY over 1 hour. The laxative effect begins in about 2 hours. BE SURE TO DRINK AT LEAST 3 GLASSES OF WATER OR JUICE AFTER TAKING EACH DOSE OF THE prep.( Each Glass =350cc)
3. At 12:00 Noon, Take 2 Dulcolax tablets and 4 tablets of K-PHOS NEUTRAL, along with 3 glasses of water/Juice.(Each glass =350cc).
ON THE DAY of your procedure:
1. Take all of your usual medicines and 1 tablet of Reglan (10mg). Do Not Take Coumadin, Plavix, or Aspirin. If you take INSULIN, take 1/2 your usual dose.
2. If you have a medical condition requiring antibiotics before or after procedures, we will determine whether they are needed for your colonoscopy.
3. STOP CLEAR LIQUIDS 4 HOURS BEFORE YOUR PROCEDURE (except for small amount of water with medications). DO NOT EAT OR DRINK ANYTHING UNTIL AFTER YOUR PROCEDURE.
4. Wear loose-fitting, comfortable clothes.
5. Read the consent form. You will be asked to sign the form before your procedure.
Please bring these things WITH YOU to your procedure:
1. A list of all of your medications, including the doses
2. Your identification or insurance card
3. The name and phone number of your escort.
AFTER your procedure:
1. You will be monitored in the Endoscopy Unit recovery area for 20-30 minutes.
2. You may have some abdominal bloating after the procedure. It should resolve within an hour.
4\. You may eat your normal diet after the procedure.
5\. You may return to work the day after the procedure.
HELPFUL HINTS FOR PATIENTS UNDERGOING COLONOSCOPY
1.Use moist wipes (baby wipes) instead of toilet paper.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PREVENTION AND TREATMENT
PATIENTS 50 YEARS AND OLDER REQUIRE SCREENING COLONOSCOPY. PATIENTS WITH FAMILY HISTORY OF COLON CANCER WILL REQUIRE IT BEFORE THE AGE OF 50.
AB PREP
Potassium phosphate and Sodium Phosphate,(in the form of K-phos neutral 8 tablets.(Bisacodyl)6tablets. The third medication is (Metoclopramide).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AB PREP
Potassium phosphate and Sodium Phosphate,(in the form of K-phos neutral 8 tablets.(Bisacodyl)6tablets. The third medication is (Metoclopramide).
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
12 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institutes of Health (NIH)
NIH
Long Neck Medical Enterprises
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Long Neck Medical Enterprises
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
SEMAAN M ABBOUD, MD
Role: PRINCIPAL_INVESTIGATOR
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cedar Tree Surgical Center
Millsboro, Delaware, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AB1
Identifier Type: -
Identifier Source: secondary_id
ABBPREP1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.